| |
| |
|
| Insider
Information: |
Sigal Elliot |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
148,221 |
|
|
Indirect Shares
|
78,638 |
|
|
| Direct
Value |
$5,965,895 |
|
|
|
Indirect Value
|
$5,479,085 |
|
|
| Total
Shares |
226,859 |
|
|
| Total
Value |
$11,444,981 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, CSO & President R... |
2013-06-03 |
148,221 |
2013-06-03 |
47,079 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2017-06-15 |
0 |
Premium* |
|
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2015-02-04 |
31,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2009-12-23 |
4 |
S |
$0.00 |
$0 |
D/D |
(12,594) |
153,040 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2010-03-15 |
4 |
S |
$25.94 |
$1,233,784 |
D/D |
(47,563) |
142,222 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-05-16 |
4 |
S |
$28.90 |
$2,046,265 |
D/D |
(70,805) |
372,572 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-05-18 |
4 |
S |
$28.70 |
$20,952 |
D/D |
(730) |
356,201 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2012-12-11 |
4 |
S |
$33.00 |
$5,189,481 |
I/I |
(157,257) |
37,412 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2013-02-08 |
4 |
S |
$36.79 |
$8,266,897 |
D/D |
(224,705) |
89,429 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2013-04-29 |
4 |
S |
$39.90 |
$4,188,026 |
D/D |
(104,918) |
153,493 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2013-04-29 |
4 |
S |
$39.97 |
$1,829,947 |
I/I |
(45,783) |
9,550 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2013-04-30 |
4 |
S |
$39.65 |
$91,076 |
I/I |
(2,297) |
9,091 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2013-04-30 |
4 |
S |
$39.61 |
$14,004,254 |
D/D |
(353,509) |
105,889 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2013-05-30 |
4 |
S |
$47.23 |
$6,778,497 |
D/D |
(143,521) |
132,993 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2013-06-03 |
4 |
S |
$48.18 |
$4,030,112 |
D/D |
(83,647) |
148,221 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2017-11-28 |
4 |
S |
$72.43 |
$2,100 |
D/D |
(29) |
11,214 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2010-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
72,043 |
223,044 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2010-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,875 |
196,526 |
0 |
- |
|
| MJN |
Mead Johnson Nutrition Co |
Director |
– • – |
2011-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,160 |
15,110 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
116,000 |
250,496 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,062 |
212,462 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,452 |
214,559 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,875 |
217,979 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-05-16 |
4 |
OE |
$28.90 |
$7,502,803 |
D/D |
259,600 |
470,838 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-05-18 |
4 |
OE |
$28.70 |
$5,326,321 |
D/D |
185,579 |
356,931 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,714 |
217,616 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,062 |
227,439 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,365 |
270,287 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
